ArticleMetabolic brain disease2024

Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort study.

Farnoosh Usefi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.